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Background-—Plaque rupture and erosion are the 2 most common mechanisms for acute coronary syndromes. However, the
outcome of these 2 distinct pathologies in patients with acute coronary syndromes has never been studied.
Methods and Results-—We retrospectively studied 141 patients with acute coronary syndromes who underwent optical coherence
tomography (OCT) imaging of the culprit lesion prior to stenting from the Massachusetts General Hospital OCT Registry.
Management (stent versus no stent), poststent OCT ﬁndings, and outcomes were compared. Among the 141 culprit lesions,
rupture was found in 79 (56%) patients and erosion in 62 (44%). Stent implantation was performed in 77 (97.5%) patients with
rupture versus 49 (79.0%) in those with erosion (P<0.001). Immediately after percutaneous coronary intervention, OCT showed a
higher incidence of malapposition (37.5% versus 7.3%, P<0.001), thrombus (59.4% versus 14.6%, P<0.001), and protrusion (93.8%
versus 73.2%, P=0.008) in the rupture group compared with the erosion group. Plaque rupture was associated with a higher
incidence of no reﬂow or slow ﬂow and distal embolization. Although cardiac event rates were comparable between the two groups
at the 1-year follow-up, none of the erosion patients who were treated conservatively without stenting had adverse cardiac events.
Conclusions-—Unfavorable poststent OCT ﬁndings were more frequent in rupture patients compared with erosion patients. A
subset of erosion patients who were treated conservatively without stenting remained free of adverse cardiac events for up to
1 year. ( J Am Heart Assoc. 2017;6:e004730. DOI: 10.1161/JAHA.116.004730.)
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A cute coronary syndrome (ACS) is caused by coronaryplaque rupture (PR), plaque erosion (PE), or rarely
calciﬁed nodule resulting in occlusive thrombus formation.1,2
Ruptured plaque is characterized by a disrupted ﬁbrous cap
overlying a large necrotic core, and extensive inﬂammation.
Eroded plaque typically shows an absence of superﬁcial lipid,
less inﬂammation, and less obstructive lumen. Currently,
patients with ACS are uniformly treated with stenting,
regardless of underlying culprit lesion pathology (PR or PE).
Although an overall favorable beneﬁt was observed in the
invasive strategy group as compared with the conservative
group in several randomized clinical trials, subgroup analyses
suggest that this strategy does not provide an equivalent level
of beneﬁt in all patients, such as women and current
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smokers.3–6 Limited data from the pathology and in vivo
studies suggest that underlying plaque morphology other than
clinical characteristics may play a critical role in determining
early and long-term outcomes in response to stent implan-
tation.7,8 In light of the relatively well-preserved vascular
structure and less severe luminal narrowing,1,2,9 it is
conceivable that ACS caused by PE without signiﬁcant luminal
narrowing may be stabilized by effective antithrombotic
treatment without stent implantation. This conservative
strategy would avoid both early (vessel dissection, distal
embolism, and acute stent thrombosis) and late (restenosis,
neoatherosclerosis, and late and very late stent thrombosis)
complications of stent implantation.10–14 Indeed, few reports
with a small number of cases have suggested that a subset of
patients with ST-segment elevation myocardial infarction
caused by PE might be treated by antithrombotic therapy
with favorable outcome.2,15,16 However, data on the out-
comes of patients with ACS caused by rupture or erosion are
limited.
Optical coherence tomography (OCT) has recently been
introduced as a high-resolution intravascular imaging modality
that enables in vivo diagnosis of PE as well as evaluation of
vascular response to stent implantation.2,17 In the present
study, we investigated the acute stent complications (dissec-
tion, malapposition, and intrastent tissue prolapsed) and
1-year outcomes in patients with ACS caused by PR versus
erosion.
Methods
Study Populations
From August 2010 to September 2013, a total of 710 patients
with ACS who underwent OCT imaging were enrolled in the
Massachusetts General Hospital OCT Registry (http://www.
clinicaltrials.gov: NCT01110538). A total of 421 patients were
excluded for the following reasons: (1) no preprocedure OCT
imaging (n=69); (2) no poststenting imaging (n=304); (3) in-
stent thrombosis or restenosis (n=33); (4) coronary artery
bypass grafting (n=3); or (5) unidentiﬁable culprit lesions
(n=12). Of 289 patients with de novo lesions, 109 patients
were additionally excluded for the following reasons: (1) poor
image quality (n=22); (2) covered stent (n=6); (3) predilatation
before OCT imaging (n=50); (4) massive thrombus (n=6); or
(5) missing clinical data (n=25). Finally, 141 patients with 141
identiﬁable culprit lesions were included in the analysis,
including 79 patients with PR and 62 with PE (Figure 1). The
culprit lesion was identiﬁed on the basis of coronary
angiogram, stress test, ECG, left ventriculogram, or echocar-
diogram. After OCT imaging, percutaneous coronary interven-
tion (PCI) was performed according to the local practice. The
decision to perform aspiration thrombectomy, balloon
angioplasty, or stent implantation was left at the operator’s
discretion.
ST-segment elevation myocardial infarction was deﬁned as
continuous chest pain that lasted >30 minutes, arrival at the
hospital within 12 hours from the onset of symptoms, ST-
segment elevation >0.1 mV in >2 contiguous leads or new
left bundle branch block on the 12-lead ECG, and elevated
cardiac markers. Non–ST-segment elevation myocardial
infarction was deﬁned as ischemic symptoms in the absence
of ST elevation on the ECG with elevated cardiac markers.
Unstable angina pectoris was deﬁned as having newly
developed/accelerating chest symptoms on exertion or rest
angina within 2 weeks.
Demographic and clinical data were prospectively col-
lected. All of the images were digitally stored and submitted
to the core laboratory at Massachusetts General Hospital. The
protocol for the registry was approved by each site’s
institutional review board, and all patients provided informed
consent.
PCI Procedure and OCT Image Acquisition
After intracoronary nitroglycerine administration, the OCT
catheter was advanced distal to the culprit lesion. Imaging of
Figure 1. Study ﬂow chart. ACS indicates acute coronary
syndrome; CABG, coronary artery bypass grafting; OCT, optical
coherence tomography; PR, plaque rupture.
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the culprit lesion was then acquired using either the
commercially available time-domain (M2/M3 Cardiology
Imaging System, Lightlab Imaging/St. Jude Medical, Westford,
MA) or frequency-domain OCT C7XR system and the Dragon-
ﬂy catheter (Lightlab Imaging/St. Jude Medical, Westford, MA)
as previously reported.2,18 Aspiration thrombectomy prior to
OCT imaging was allowed in patients with large occlusive
thrombus or a thrombolysis in myocardial infarction (TIMI)
ﬂow grade <2. Predilatation, however, was not allowed. All
treatment strategies were decided on by the operators at
each institution according to local practice. At the end of the
procedure, ﬁnal OCT imaging was acquired in patients treated
with stent implantations. The images were digitally stored and
deidentiﬁed for ofﬂine analysis.
OCT Image Analysis
After the culprit lesion was identiﬁed, underlying plaque
morphology was analyzed by 2 experienced reviewers using
the previously reported criteria.2,17–19 Plaques were classiﬁed
as: (1) ﬁbrous (homogeneous, high backscattering region) or
(2) lipid (low-signal region with diffuse border).17,20 In lipid
plaques, ﬁbrous cap thickness was measured 3 times at the
thinnest part, and the average value was calculated. Lipid arc
was measured at 1-mm intervals and lipid length was
measured on the longitudinal view. Thin-cap ﬁbroatheroma
was deﬁned as a plaque with lipid content in at least 2
quadrants, with the thinnest part of the ﬁbrous cap measuring
<65 lm.21 PR was identiﬁed by the presence of ﬁbrous cap
discontinuity with a clear cavity formed inside the pla-
que.2,22,23 PE was deﬁned as a plaque with no detectable
signs of ﬁbrous cap rupture with or without thrombus
attached, including both deﬁnite and probable erosion.2,23
Thrombus was deﬁned as a mass ﬂoating in or protruding into
the lumen with a dimension of at least 250 lm. Thrombus
score was calculated as the sum of the number of quadrants
with visible thrombus. The poststent OCT ﬁndings including
edge dissection, in-stent dissection, incomplete stent appo-
sition, and tissue protrusion were assessed using the
previously reported deﬁnitions.24 Tissue protrusion was
deﬁned as a bowing of the plaque into the lumen between
stent struts. Edge dissection was deﬁned as the disruption of
the vessel luminal surface with a visible ﬂap at the proximal or
distal stent edge. In-stent dissection was deﬁned as the
disruption of the vessel luminal surface with a visible ﬂap
within the stented area. Incomplete stent apposition was
deﬁned as any strut with a distance of more than the sum of
strut thickness plus polymer thickness from the surface
reﬂection of the strut to the adjacent visible surface of the
vessel. Malapposition area was calculated as (lumen area-
stent area) in a cross-sectional image containing malap-
posed struts.
Quantitative Coronary Angiography Analysis
Angiographic images were analyzed using a quantitative
coronary angiogram analysis program (CAAS 5.10.1, Pie
Medical Imaging BV, Maastricht, the Netherlands). Reference
diameter, minimum lumen diameter, lesion length, and
percent diameter stenosis were measured.
Clinical Outcomes
Patients were followed up by telephone call or hospital visit at
6 and 12 months. The occurrence of major adverse cardiac
events was recorded, which included death from any cause,
nonfatal myocardial infarction, and revascularization.
Statistical Analysis
All statistical analyses were performed by an independent
statistician at the core laboratory. Categorical data were
compared using either chi-square test or Fisher exact test,
and are presented as counts (proportions). Continuous
variables are expressed as meanSD and compared using
the independent sample t test. All statistical analyses were
performed using SPSS version 18.0 (SPSS Inc, Chicago, IL).
P<0.05 was considered statistically signiﬁcant.
Results
Baseline Characteristics
The baseline characteristics of patients with PR and those
with OCT-erosion are summarized in Table 1. Among the 141
patients enrolled, 79 (56%) patients had PR at a culprit lesion
and 62 (44%) had OCT-erosion. The plaque characteristics of
94 patients were reported in our previous study.2 No
signiﬁcant difference was observed in sex, coronary risk
factors, laboratory ﬁndings, and medications between the 2
groups, except younger age, higher frequency of NSTE-ACS,
and higher level of high-density lipoprotein in the OCT-erosion
group.
Angiographic Findings
The culprit lesion distribution and quantitative coronary
angiogram analysis data are listed in Table 2. OCT-erosion
was most frequently detected in the left anterior descending
artery. PR was equally distributed in the LAD and right
coronary artery. There was no signiﬁcant difference in the
culprit lesion distribution between the proximal, mid, and
distal segments of coronary arteries. The minimum lumen
diameter was larger (P<0.001) and the diameter stenosis was
less severe (P=0.001) in the OCT-erosion group compared
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with the PR group. Patients with PR had a higher incidence of
multivessel disease (P<0.001) and more complicated lesion
type (type B2/C) (P<0.001) compared with those with OCT-
erosion.
Procedural Characteristics
Procedural data are summarized in Table 3. Of the 79 patients
with PR, 77 (97.5%) were treated with stent implantation
(drug-eluting stent=86, bare metal stent=12). Among the 62
patients with OCT-erosion, 49 (79.0%) were treated with stent
implantation (drug-eluting stent=57, bare metal stent=4). The
mean stent length and mean stent diameter were similar
between the two groups. Compared with patients with PR,
those with OCT-erosion had higher baseline thrombolysis in
myocardial infarction ﬂow grade, lower incidence of throm-
bolysis in myocardial infarction ﬂow grade ≤2 after stenting,
and lower incidence of distal embolization.
OCT Findings After PCI
Post-PCI OCT ﬁndings in patients with PR and OCT-erosion are
listed in Table 4. Post-PCI OCT imaging was acquired in 61
patients with PR and in 46 with OCT-erosion. Patients with PR
had a higher incidence of in-stent dissection or thrombus,
compared with those with OCT-erosion after stent implanta-
tion. The incidence of malapposition was signiﬁcantly higher
and the malapposed area was signiﬁcantly larger in patients
Table 1. Baseline Characteristics
Overall (N=141) PR (n=79) OCT-Erosion (n=62) P Value
Age, y 57.911.5 60.310.4 54.812.1 0.005
Male 113 (80.1) 65 (82.3) 48 (77.4) 0.473
Risk factors
Current smoker 51 (36.2) 26 (32.9) 25 (40.3) 0.363
Diabetes mellitus 33 (23.4) 19 (24.1) 14 (22.6) 0.838
Hyperlipidemia 96 (68.1) 58 (73.4) 38 (61.3) 0.125
Hypertension 81 (57.4) 51 (64.6) 30 (48.4) 0.054
Family history of CAD 14 (9.9) 9 (11.4) 5 (8.1) 0.512
Obesity (BMI >25 kg/m2) 72 (51.1) 41 (51.9) 31 (50) 0.823
Chronic kidney disease 6 (4.3) 3 (3.8) 3 (4.8) 1.000
Previous CABG 1 (0.7) 1 (1.3) 0 1.000
Prior MI 17 (12.1) 11 (13.9) 6 (9.7) 0.442
LVEF, % 61.710.1 61.39.8 62.210.7 0.659
Presentation
STEMI 66 (46.8) 46 (58.2) 20 (32.3) 0.002
NSTE-ACS 75 (53.2) 33 (41.8) 42 (67.7)
Laboratory variables
TC, mg/dL 177.746.1 18043.8 174.348.9 0.435
HDL-C, mg/dL 46.620.6 42.516.7 51.423.7 0.013
LDL-C, mg/dL 100.335.1 104.337.3 95.631.9 0.156
TG, mg/dL 167.5104.4 182.5119.8 149.479.5 0.060
Creatinine, mg/dL 0.900.22 0.930.21 0.870.23 0.100
Medications at admission
Statin 48 (34.0) 30 (38.0) 18 (29.0) 0.266
b-Blocker 33 (23.4) 21 (26.6) 12 (19.4) 0.314
ARB/ACEI 35 (24.8) 18 (22.8) 17 (27.4) 0.527
Data are presented as meanSD, or number (percentage). The P values were calculated using t tests for continuous variables and Fisher exact test tests for categorical variables. ACEI
indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery disease; HDL-
C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTE-ACS, non–ST-segment elevation
acute coronary syndrome; OCT, optical coherence tomography; PR, plaque rupture; STEMI, ST-segment elevation myocardial infarction; TC, total cholesterol; TG, triglyceride.
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with PR than in those with OCT-erosion. The representative
cases of PE and PR are shown in Figures 2 and 3.
Clinical Outcomes at 1-Year Follow-Up
Table 5 shows the clinical outcomes at the 1-year follow up.
Of the 141 enrolled patients, 134 (95.0%) were followed up to
1 year. Mean follow-up time was 367.322.3 days. Statis-
tically, no signiﬁcant differences were observed between the
2 groups in rates of death, myocardial infarction, target lesion
revascularization, or nontarget lesion revascularization. How-
ever, the rate of revascularization in patients with PR was
numerically higher than those with OCT-erosion (12.5%
versus 6.5%, P=0.238). Two of 79 (2.5%) patients in the
rupture group and 13 of 62 (21.0%) in the erosion group were
treated conservatively without stent implantation. Clinical
outcomes of patients with PR and OCT-erosion stratiﬁed by
treatment strategy are summarized in Table S1. At 1-year
follow-up, 1 of 2 patients in the rupture group who was
treated medically died. All 13 patients in the erosion group
who were treated medically remained free of adverse events
for up to 1 year.
Discussion
This study shows that, in the real world, patients with ACS
caused by PE were more likely to be treated conservatively
compared with those caused by PR (21.0% versus 2.5%).
Among the patients who were treated with stent implantation,
patients with PR had a higher incidence of malapposition,
Table 3. Procedural Data
PR (n=79)
OCT-Erosion
(n=62) P Value
PCI procedure
Stent treatment 77 (97.5) 49 (79.0) <0.001
No of stent/culprit lesion 1.270.52 1.260.51 0.887
Total stent length, mm 34.220.7 30.118.0 0.192
Mean stent diameter, mm 3.20.43 3.10.43 0.275
Baseline TIMI flow grade
TIMI flow grade 0 10 (12.7) 2 (3.2) 0.0013
TIMI flow grade 1 5 (6.3) 2 (3.2)
TIMI flow grade 2 25 (31.6) 8 (12.9)
TIMI flow grade 3 39 (49.4) 50 (80.7)
Final TIMI flow grade ≤2 14 (17.7) 2 (4.8) 0.015
Distal embolization 27 (34.2) 5 (8.1) <0.001
Data are presented as number (percentage) or meanSD. P values were calculated using
t test for continuous variables and Fisher exact test for categorical variables. OCT
indicates optical coherence tomography; PCI, percutaneous coronary intervention; PR,
plaque rupture; TIMI, thrombolysis in myocardial infarction.
Table 4. Post-PCI OCT Findings (Stent-Based Analysis)
PR
(n=61 Stents)
OCT-Erosion
(n=46 Stents) P Value
Edge dissection 9/61 (14.8) 4/38 (10.5) 0.764
Proximal 2/56 (3.6) 1/38 (2.6) 0.731
Distal 7/61 (11.5) 3/38 (7.9) 0.817
In-stent dissection 35 (57.4) 17 (37.0) 0.036
Thrombus 35 (57.4) 8 (17.4) <0.001
Thrombus score 12.113.9 7.911.5 0.095
Thrombus volume, mm3 1.231.86 0.420.41 0.027
Malapposition 27 (44.3) 10 (21.7) 0.015
Malapposed area, mm2 0.830.39 0.530.52 0.045
MLA, mm2 6.01.7 6.12.0 0.695
MLD, mm 2.60.4 2.70.8 0.688
Maximum stent area, mm2 8.52.3 8.22.5 0.470
Data are presented as number (percentage) or meanSD. P values were calculated using
t test for continuous variables and Fisher exact test for categorical variables. MLA
indicates minimum luminal area; MLD, minimum luminal diameter; OCT, optical
coherence tomography; PCI, percutaneous coronary intervention; PR, plaque rupture.
Table 2. Angiographic Findings
PR (n=79)
OCT-Erosion
(n=62) P Value
Culprit vessel 0.009
LAD 32 (40.5) 40 (64.5)
LCX 16 (20.3) 11 (17.7)
RCA 31 (39.2) 11 (17.7)
Lesion location 0.082
Proximal 34 (43) 20 (32.3)
Mid 16 (20.3) 23 (37.1)
Distal 29 (36.7) 19 (30.6)
QCA data
Reference
diameter, mm
3.320.76 3.470.95 0.295
Minimum lumen
diameter, mm
0.960.46 1.590.82 <0.001
Diameter stenosis, % 69.2212.3 55.817.5 0.001
Multivessel disease 55 (69.6) 20 (32.3) <0.001
ACC/AHA lesion class <0.001
Type A/B1 10 (12.7) 28 (45.2)
Type B2/C 69 (87.3) 34 (54.8)
Data are presented as meanSD or number (percentage). P values were calculated using
t test for continuous variables and chi-square test for categorical variables. ACC/AHA
indicates American College of Cardiology/American Heart Association; LAD, left anterior
descending coronary artery; LCX, left circumﬂex artery; OCT, optical coherence
tomography; PR, plague rupture; QCA, quantitative coronary angiogram analysis; RCA,
right coronary artery.
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tissue protrusion, and thrombus compared with those with PE.
At the 12-month follow-up, the rate of revascularization in
patients with PR was numerically higher than those with OCT-
erosion although no statistical difference was observed.
Importantly, patients with erosion who were treated conser-
vatively were free of cardiovascular events up to the 1-year
follow-up.
Impact of Underlying Plaque Morphology on
Management of ACS
PEs are responsible for 25% to 44% of ACS cases. PE is
characterized by a less occlusive plaque with relatively
preserved vascular integrity.1,2,25–27 The autopsy study
showed that ruptured plaque is often signiﬁcantly obstructive
and has a large plaque burden and a large necrotic core with
an overlying disrupted ﬁbrous cap, which is attenuated and
inﬂamed. Disruption of the ﬁbrous cap exposes a great
amount of highly thrombogenic necrotic core to circulating
platelets, leading to occlusive thrombus and acute ischemic
events.28 In contrast, PE often has a less severe obstruction, a
less superﬁcial necrotic core, and a smaller plaque bur-
den.26,29 Furthermore, luminal thrombus in PE has been
attributed to apoptosis or denudation of superﬁcial endothe-
lial cells and is rich in platelets. These distinct characteristics
associated with PE provide rationale for conservative
treatment with potent antithrombotic therapy without stent-
ing. Indeed, patients with PE have a more favorable response
to thrombolytic therapy compared with those with PR.23
Current treatment of ACS is routine PCI with stenting,
regardless of underlying pathologies. The culprit plaque
morphology is not routinely evaluated. Therefore, the impact
of underlying lesion characteristics on treatment strategy
selection has never been investigated in the setting of ACS.
Although our investigation was a retrospective study without
predeﬁned criteria for the selection of treatment strategy and
all of the patients were treated according to local practice
without knowledge of underlying pathology, patients with PE
were more frequently treated “conservatively” without stent
implantation compared with patients with PR (21.0% versus
2.5%, P<0.001). Of the 62 patients with PE, 13 who had
moderate stenosis were treated with antithrombotic therapy
without stent implantation. Remarkably, those who were
treated conservatively had no adverse cardiac events during
the 1-year follow- up. In contrast, 7 events were observed
among the 49 patients who were treated with stenting.
Consistent with this ﬁnding, Prati et al retrospectively inves-
tigated 31 patients with ST-segment elevation myocardial
infarction.30 After thrombus was removed by thrombectomy,
OCT showed the intact ﬁbrous cap without evidence of PR and
no signiﬁcant residual obstruction. Among these 31 patients,
19 were treated with stents and 12 were treated with only
B C
A
Figure 2. Representative optical coherence tomography (OCT) images of plaque erosion. A 28-year-old
man with ST-segment elevation myocardial infarction was admitted after 2 hours of chest pain. Results
from index angiogram showed total occlusion in the mid–left anterior descending artery (LAD; white arrow,
A). Angiogram results after thrombus aspiration showed a mild stenosis in the mid-LAD (B). Cross-sectional
image of the culprit lesion shows residual white thrombus without evidence of ruptured ﬁbrous cap (yellow
arrows, C). The patient was treated with medical therapy without stent implantation.
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antithrombotic therapy without angioplasty or stenting. None
of these 12 patients required an additional revascularization
during the 12-month follow-up.30
Underlying Plaque Morphology and Clinical
Outcomes After PCI
In our previous study of the mechanism responsible for ACS,
lipid plaques were less frequently detected in patients with
OCT-erosion than in those with PR. When lipids were present,
the overlying ﬁbrous cap was thicker, the lipid arc was
smaller, and the lipid length was shorter in patients with OCT-
erosion compared with those with PR.2 Ruptured plaque
releases highly thrombogenic substrates, which may induce
recurrent local thrombosis and distal embolization, perturbing
the coronary microcirculation. These ﬁndings suggest that PR
may be associated with worse outcomes after stenting.
Higuma et al27 reported that PR was associated with worse
myocardial perfusion after PCI compared with PE. In the
present study, we also found that PR had a higher incidence of
acute stent complications (in-stent dissection, tissue protru-
sion, malapposition, and thrombus) and higher frequency of
distal embolization. Recently, Niccoli et al31 demonstrated
that patients with PR have a worse prognosis after 3-year
follow-up when compared with those with PE, which is mainly
driven by a higher risk of revascularization and unstable
angina. In our study, we did not observe different clinical
outcomes between the 2 groups, which may be attributed to
the small sample size and short follow-up period. However,
the favorable clinical outcomes in patients with erosion
treated conservatively highlights the new concept that in a
subset of patients with ACS caused by PEs, conservative
therapy without stent implantation might be feasible and safe.
A B C
D E F
Figure 3. Representative optical coherence tomography (OCT) images of plaque rupture. A 60-year-old woman with ST-segment elevation
myocardial infarction was admitted after 11 hours of chest pain. Results from diagnostic angiogram showed total occlusion in the proximal left
anterior descending artery (LAD). Angiogram results after thrombectomy demonstrates dissection lesion in the proximal LAD (white arrow, left
upper panel). Cross-sectional OCT images of the culprit lesion show disrupted ﬁbrous cap (white arrows) and cavity (asterisk) formation
(A through C). The patient was treated with a drug-eluting stent (3.0918 mm). Poststenting OCT revealed in-stent thrombus (red arrows, D),
malapposed struts (white arrows, E), and stent protrusion (yellow arrows, F).
Table 5. Clinical Outcomes at 1 Year
Events
Overall
(N=134) PR (n=72)
OCT-Erosion
(n=62) P Value
Death 2 (1.5) 1 (1.4) 1 (1.6) 1.000
Acute MI or ACS 3 (2.2) 1 (1.4) 2 (3.2) 0.596
Revascularization 13 (9.7) 9 (12.5) 4 (6.5) 0.238
TLR 6 (4.6) 5 (6.9) 1 (1.6) 0.216
Non-TLR 7 (5.2) 4 (5.6) 3 (4.8) 1.000
Overall MACE 17 (12.7) 10 (13.9) 7 (11.3) 0.652
Data are presented as number (percentage). Comparisons of the events between the two
groups were performed using Fisher exact test. ACS indicates acute coronary syndrome;
MACE, major adverse cardiovascular events; MI, myocardial infarction; OCT, optical
coherence tomography; PR, plaque rupture; TLR, target lesions revascularization.
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This concept was prospectively tested in a recent clinical trial
that was performed by our group.32 If this conservative
approach without a metallic stent or polymer scaffold proves
to be effective and safe, it may become a new treatment
paradigm for one fourth of patients with ACS. Randomized
trials will be needed to reproduce this pilot data and to
evaluate the long-term outcomes of this new strategy.
Limitations
Several limitations need to be mentioned in this study. First,
this is a retrospective analysis of a small number of patients.
Because of the retrospective nature of the analysis, there was
no systematic decision process for how to treat patients.
However, although this was a retrospective study, it may
provide important evidence for better individualized manage-
ment of patients with ACS based on underlying lesion
characteristics. In addition, the registry included only patients
who underwent OCT according to the operator’s discretion.
Therefore, the issue of selection bias cannot be avoided.
Second, the underlying plaque characteristics might be
obscured by residual thrombus (speciﬁcally, red thrombus) in
some cases. Although we excluded cases with massive
residual thrombus after thrombus aspiration to avoid misclas-
siﬁcation of culprit plaques, we have to acknowledge that
some ruptured cases might be misdiagnosed as erosion due to
invisibility of the ruptured site, which was hidden underneath
the thrombus. Third, thrombus aspiration was performed to
facilitate reperfusion prior to OCT imaging. Although care was
taken to avoid excessive mechanical injury during thrombec-
tomy, it is possible that this procedure may have altered the
morphologic features of the underlying plaque. Therefore, we
cannot exclude that in some patients, PR was iatrogenic, being
caused by thrombus aspiration. Fourth, due to safety con-
cerns, 16 (20.8%) patients in the rupture group did not undergo
poststenting OCT imaging, whereas only 3 (6.1%) in the
erosion group did not undergo poststenting OCT imaging
(P<0.05). This difference might result in selection bias in our
study. However, the main ﬁndings of the present study are
unlikely changed even though poststenting OCT imaging was
performed in patients with worse conditions.
Conclusions
Patients with PE are more likely to be treated with medical
therapy without stent implantation compared with patients
with PR. Patients with PE treated conservatively remained free
of major adverse cardiac events for up to 1 year. Patients
with PR had worse vascular response to stent implantation
with a higher incidence of malapposition, tissue protrusion,
and thrombus, compared with patients with PE.
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Table S1. Clinical outcomes of patients with stent implantation and without stent 
implantation stratified by treatment strategy 
Data are presented as n (%). MI = myocardial infarction; ACS = acute coronary 
syndrome; TVR = target vessel revascularization; TLR = target lesions 
revascularization. 
 
 
 
PR   
 
OCT-
erosion 
 
 
 
Non-stent Stent  p Non-stent Stent  p 
Death  1(50) 0(0) 1.0 0(0) 1(2.0) 0.76 
Acute MI or ACS 0(0) 1(1.4) 0.94 0(0) 2(4.0) 0.66 
Revascularization  0(0) 9(12.9) 0.72 0(0) 4(8.0) 0.54 
 TLR 0(0) 5(7.1) 0.79 0(0) 1(2.0) 0.76 
 Non-TLR 0(0) 4(5.7) 0.82 0(0) 3(6.0) 0.59 
Any events 1(50) 9(12.9) 0.21 0(0) 7(14.0) 0.41 
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